Maintenance Therapy With Alternating Azacytidine and Lenalidomide Cycles In Elderly (≥ 60) Fit Patients (Pts) With Poor Prognosis AML In First Complete Remission (CR) After Lia Induction. A Phase II Multicentric Goelams Trial

被引：2
|
作者：
Hunault-Berger, Mathilde
Randriamalala, Edouard
Schmidt-Tanguy, Aline
Himberlin, Chantal
Choufi, Bachra
Bonmati, Caroline
Cahn, Jean Yves
Couturier, Marie-Anne
Deconinck, Eric
Marolleau, Jean Pierre
Orisni-Piocelle, Frederique
Delaunay, Jacques
Tavernier, Emmanuelle
Recher, Christian
Lissandre, Severine
Ojeda-Uribe, Mario
Sanhes, Laurence
Sutton, Laurent
Banos, Anne
Lioure, Bruno
Lamy, Thierry
Bouscary, Didier
Saad, Alain
Rouille, Valerie
Guardiola, Philippe
Luquet, Isabelle
Bene, Marie-Christine
Dreyfus, Francois
Ifrah, Norbert
Pigneux, Arnaud
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2691.2691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2691
引用
收藏
页数：2
相关论文
共 7 条
  • [1] Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial
    Hunault, Mathilde
    Maillard, Nathalie
    Tanguy-Schmidt, Aline
    Himberlin, Chantal
    Choufi, Bachra
    Bonmati, Caroline
    Couturier, Marie Anne
    Deconinck, Eric
    Marolleau, Jean Pierre
    Orsini-Piocelle, Frederique
    Delaunay, Jacques
    Tavernier, Emmanuelle
    Recher, Christian
    Lissandre, Severine
    Ojeda-Uribe, Mario
    Sanhes, Laurence
    Sutton, Laurent
    Banos, Anne
    Lioure, Bruno
    Bernard, Marc
    Bouscary, Didier
    Saad, Alain
    Rouille, Valerie
    Guardiola, Philippe
    Luquet, Isabelle
    Bene, Marie C.
    Dreyfus, Francois
    Cahn, Jean-Yves
    Pigneux, Arnaud
    Ifrah, Norbert
    [J]. BLOOD, 2015, 126 (23)
  • [2] Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
    M Hunault-Berger
    N Maillard
    C Himberlin
    C Recher
    A Schmidt-Tanguy
    B Choufi
    C Bonmati
    M Carré
    M-A Couturier
    E Daguindau
    J-P Marolleau
    F Orsini-Piocelle
    J Delaunay
    E Tavernier
    S Lissandre
    M Ojeda-Uribe
    L Sanhes
    L Sutton
    A Banos
    L M Fornecker
    M Bernard
    D Bouscary
    A Saad
    M Puyade
    V Rouillé
    I Luquet
    M C Béné
    J-F Hamel
    F Dreyfus
    N Ifrah
    A Pigneux
    [J]. Blood Cancer Journal, 2017, 7 : e568 - e568
  • [3] Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial
    Hunault-Berger, M.
    Maillard, N.
    Himberlin, C.
    Recher, C.
    Schmidt-Tanguy, A.
    Choufi, B.
    Bonmati, C.
    Carre, M.
    Couturier, M-A
    Daguindau, E.
    Marolleau, J-P
    Orsini-Piocelle, F.
    Delaunay, J.
    Tavernier, E.
    Lissandre, S.
    Ojeda-Uribe, M.
    Sanhes, L.
    Sutton, L.
    Banos, A.
    Fornecker, L. M.
    Bernard, M.
    Bouscary, D.
    Saad, A.
    Puyade, M.
    Rouille, V.
    Luquet, I.
    Bene, M. C.
    Hamel, J-F
    Dreyfus, F.
    Ifrah, N.
    Pigneux, A.
    [J]. BLOOD CANCER JOURNAL, 2017, 7 : e568 - e568
  • [4] Tipifarnib (Zarnestra, R115777) as maintenance therapy for adults in complete remission (CR) following induction and consolidation therapies for poor-risk acute myelogenous leukemia: A phase II trial
    Karp, JE
    Gojo, I
    Greer, J
    Smith, BD
    Klein, M
    Lancet, JE
    Gore, SD
    Morris, L
    Thibault, A
    Rybak, ME
    Wright, JJ
    [J]. BLOOD, 2005, 106 (11) : 780A - 781A
  • [5] CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: Results from the phase III QUAZAR AML-001 trial.
    Ravandi, Farhad
    Wei, Andrew
    Dohner, Hartmut
    Dombret, Herve
    Ossenkoppele, Gert J.
    Pfeilstocker, Michael
    Thol, Felicitas
    Feldman, Georg
    Voso, Maria Teresa
    Marlton, Paula
    Harvey, Michael
    Santini, Valeria
    Fianchi, Luana
    Candoni, Anna
    La Torre, Ignazia
    Skikne, Barry
    Kumar, Keshava
    Dong, Qian
    Beach, C. L.
    Roboz, Gail J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] GEM2017FIT Trial: Induction Therapy with Bortezomib-Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus/Minus Daratumumab (D), 18 Cycles, Followed By Consolidation and Maintenance Therapy with Lenalidomide and Daratumumab: Phase III, Multicenter, Randomized Trial for Elderly Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients Aged between 65 and 80 Years
    Mateos, Maria-Victoria
    Paiva, Bruno
    Cedena Romero, Maria Teresa
    Puig, Noemi
    Sureda Balari, Anna Maria
    Oriol, Albert
    Ocio, Enrique M.
    Rosinol, Laura
    Gonzalez-Montes, Yolanda
    Jose Bargay, Juan
    Gonzalez Garcia, Esther
    Hernandez Garcia, Miguel Teodoro
    Ramirez, Angel
    Suarez-Cabrera, Alexia
    Blanchard, Maria-Jesus
    Garzon, Sebastian
    Casado Montero, Luis Felipe
    Cabanas Perianes, Valentin
    Perez De Oteyza, Jaime
    Gironella, Mercedes
    Martinez-Lopez, Joaquin
    Ana-Isabel-Teruel
    Delgado, Pilar
    Prieto, Elena
    Lahuerta Palacios, Juan Jose
    Blade, Joan
    San Miguel, Jesus
    [J]. BLOOD, 2023, 142
  • [7] Phase II study of consolidation treatment with holmium-166 (166Ho) TARE followed by maintenance systemic therapy (MT) in unresectable liver-limited (ULL) colorectal cancer (CRC) patients (pts) after standard first-line induction therapy: The HAITI trial
    Borelli, B.
    Bargellini, I.
    Carullo, M.
    Boni, G.
    Pietrantonio, F.
    Boccaccio, C.
    Antonuzzo, L.
    Conca, V.
    Tamberi, S.
    Taravella, A.
    De Marco, S.
    Rihawi, K.
    Vannini, F.
    Bozzi, E.
    Dell'Aquila, E.
    Bianchi, A. Sartore
    Delliponti, L.
    Cremolini, C.
    Crocetti, L.
    Masi, G.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S72 - S73
1